Fulcrum Therapeutics, Inc. Gains 38.52%

Tue, Aug 22, 2023 at 07:07 PM
Fulcrum Therapeutics, Inc. Gains 38.52%

Fulcrum Therapeutics, Inc. (FULC:NASDAQ) shot up at $5.43, representing a gain of 38.5%. On Tue, Aug 22, 2023, FULC:NASDAQ touched a New 2-Week High of $5.43. The stock got featured on our News Catalysts scanner on Tue, Aug 22, 2023 at 12:14 PM in the 'BIOTECH' category. From Tue, Aug 08, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days

About Fulcrum Therapeutics, Inc. (FULC:NASDAQ)

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine which employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle wasting disorder that leads to physical impairments and disability.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.